Home Consent Form Library Neurology & NeurosurgeryDeep Brain Stimulation

Neurology & Neurosurgery Template Tool

Free Deep Brain Stimulation Consent Form Template

Operational & Compliance DisclaimerDisclaimer: This template is a sample for operational and administrative purposes only. ConsentCollect is a software platform, not a law firm or a healthcare provider. Consult with qualified legal counsel and medical directors to ensure compliance with local regulations before deploying any clinical consent form.

Professional medical consent form template for Deep Brain Stimulation

Informed Consent for Deep Brain Stimulation (DBS) Implantation

Patient Informed Consent Documentation

Patient and Surgical Information

Neurosurgical Center

Neurosurgeon

Movement Disorder Neurologist

Patient Full Legal Name

Date of Birth

MRN

Clinical Indication

Planned Brain Target

Nature and Purpose of the Procedure

Deep Brain Stimulation (DBS) is a neurosurgical procedure in which one or two thin electrode arrays are implanted into precisely targeted brain regions responsible for abnormal movement circuits, connected by subcutaneous wires to an implantable pulse generator (IPG) neurostimulator placed under the skin of the chest wall. The system delivers continuous adjustable electrical stimulation that modulates the targeted brain circuit to suppress abnormal neurological symptoms. DBS is indicated for movement disorders (Parkinson's disease, essential tremor, dystonia) and selected psychiatric conditions (obsessive-compulsive disorder) that have not responded adequately to maximum pharmacological management. The procedure involves: (1) Preoperative stereotactic MRI target planning; (2) Frame or frameless stereotactic electrode implantation, typically performed with the patient awake (to allow real-time neurophysiological mapping and intraoperative clinical testing of stimulation effects); (3) A second surgical stage under general anesthesia to implant the IPG neurostimulator in the chest and connect the system. The DBS system requires ongoing programming by a specialized neurologist and battery replacement (via minor surgery) every 3 to 5 years, or continuous recharging if a rechargeable IPG is used.

Awake Craniotomy Disclosure

The electrode implantation stage is typically performed while the patient is awake and alert, under local anesthesia and conscious sedation. Being awake allows the surgical team to perform microelectrode recording to map the target brain region and to test stimulation effects in real time (tremor suppression, speech testing, and assessment of side effects). Although patients generally tolerate the procedure well, you may experience: awareness of skull pin placement, headframe application, and cranial drilling; transient neurological symptoms during testing; anxiety or claustrophobia during the procedure. An anesthesia team is present throughout to manage comfort and safety. You may request sedation at any time. A trial of awake sedation can be arranged preoperatively if anxiety is significant.

Material Risks and Potential Complications

Intracranial hemorrhage: bleeding in the brain from electrode insertion, occurring in approximately 1 to 3 percent; may cause permanent neurological deficit or stroke.

Stroke: thromboembolic or hemorrhagic stroke occurring in approximately 1 percent; may cause permanent weakness, speech impairment, or cognitive change.

Electrode misplacement: failure to achieve optimal anatomical targeting, requiring electrode repositioning in approximately 3 to 5 percent of implantations.

Hardware complications: electrode fracture, lead migration, connector failure, or IPG malfunction requiring surgical revision (occurring in 5 to 10 percent of patients over the device lifetime).

Infection: wound infection or hardware infection occurring in 2 to 5 percent; may require prolonged antibiotic therapy or hardware explantation.

Stimulation-related side effects: depending on target, may include speech slurring (dysarthria), involuntary movements, muscle contractions, visual disturbances, depression, impulsivity, or cognitive changes. Most are reversible with parameter adjustment; some may persist.

MRI restrictions: DBS systems require specific safety protocols for MRI scanning; not all MRI body regions are safe with DBS active. Patients must carry their device identification card and inform all imaging staff before any MRI procedure.

Death: a rare but recognized risk of any major neurosurgical procedure; risk is less than 0.5 percent in appropriately selected patients at specialist centers.

Alternatives to Deep Brain Stimulation

Continued optimal pharmacological therapy: medication dose adjustment, combination therapy (levodopa, dopamine agonists, MAO-B inhibitors in PD; propranolol, primidone in ET). DBS is considered when medications are no longer providing adequate control or their side effects limit titration.

Focused Ultrasound Thalamotomy (FUS): non-invasive ablative procedure for essential tremor and tremor-dominant PD targeting the Vim thalamus using high-intensity focused ultrasound. No hardware implantation; irreversible ablation; not available at all centers; currently unilateral only.

Stereotactic Radiosurgery (Gamma Knife Thalamotomy): radiosurgical lesion at Vim nucleus; delayed response over months; not reversible; risk of radiation necrosis; less commonly used.

Pallidotomy or Thalamotomy: surgical lesion at GPi or Vim thalamus; irreversible ablation; may be considered where DBS is not feasible.

Long-Term Device Management Obligations

DBS therapy requires lifelong engagement with a specialized DBS programming team. Following implantation, patients attend multiple programming sessions over the first 6 to 12 months to optimize stimulation parameters. Battery monitoring (for non-rechargeable IPGs) or daily recharging (for rechargeable systems) is required. Patients must present their DBS device identification card at all healthcare encounters, particularly before any MRI, diathermy, or cardiac electrophysiology procedures, as these may interfere with or damage the device. Travel through airport security is generally safe, but the DBS system should be disclosed. IPG battery replacement surgery is required every 3 to 5 years for non-rechargeable systems.

Expected Benefits

DBS has been shown to significantly reduce motor symptoms in appropriately selected patients. In Parkinson's disease, DBS reduces tremor, rigidity, and bradykinesia, reduces 'off' time, and often allows significant reduction in levodopa dosage (reducing levodopa-induced dyskinesias). Studies show 50 to 70 percent reduction in UPDRS motor scores. In essential tremor, DBS of the Vim thalamus provides greater than 70 percent tremor reduction in the majority of patients. In dystonia, improvement is often substantial but slower, occurring over months. DBS does not halt the underlying disease progression.

Right to Refuse or Withdraw Consent

You have the right to refuse this procedure or withdraw your consent at any time before the procedure begins without penalty or adverse effect on your medical care. DBS is an elective surgery and all pharmacological alternatives will remain available if you choose not to proceed.

Questions and Understanding Confirmation

I confirm that I have had the opportunity to review this consent form with my neurosurgeon and movement disorder neurologist. I understand the awake surgical procedure, the stimulation parameter programming commitment, and the MRI restrictions associated with the device. All my questions have been answered to my satisfaction.

Language Access and Interpreter Services

If English is not your primary language or if you require assistance communicating, a qualified medical interpreter is available at no cost. Please notify your care team before signing this document.

Copy of Consent Acknowledgment

I acknowledge that I have been offered a signed copy of this informed consent form and the DBS device patient information booklet for my own records.

Patient Authorization

I have been informed of the DBS implantation procedure, the expected benefits, the material risks including the risk of intracranial hemorrhage and stroke, and the available alternatives. I understand the long-term device management obligations and MRI restrictions. I consent to proceed with DBS implantation at the brain target indicated above.

Signatures and Verification

Patient / LAR Signature

Neurosurgeon Signature

Witness Signature

Date and Time

Document ID: CC-DEEP-BRAIN-STIMULATION-CONSENT-FORM

Need to print or customize this template?

Download a clean PDF copy or customize it in our Free Consent Builder. No account required.

Looking for a complete clinical workflow?

Standard PDF consent forms still leave your practice exposed to malpractice disputes. If you want verified patient comprehension quizzes, automated signing order tracking, biometric signature seals, and direct Epic/Cerner EHR FHIR R4 integration, then upgrade to our full ConsentCollect App.

Free Document Schema Specifications

Template Classification:Deep Brain Stimulation Layout

Target File Format:Printable PDF / HTML Structure

Customization Capability:Fully Editable Text & Checklist Fields

Licensing & Rights:Free Personal & Practice-Wide Use

How to Use the Digital Deep Brain Stimulation Consent Template

The Deep Brain Stimulation document layout available on this page is a structured administrative schema designed for neurology & neurosurgery practice managers, compliance coordinators, and healthcare operations teams. Neurosurgery consent form for DBS implantation covering awake craniotomy requirements, electrode targeting, stimulator programming, MRI restrictions, and movement disorder outcomes.

Using the ConsentCollect Free Builder, administrative staff can import this deep brain stimulation schema and configure every field to match their specific facility requirements. The builder supports drag-and-drop field reordering, custom label editing, signature block layout control, and client-side PDF generation, with no coding knowledge required and no account needed.

Once the deep brain stimulation layout is finalized, it can be printed as a high-resolution paper document, embedded into a digital patient intake kiosk, or exported as a structured JSON payload for integration into an existing EHR or practice management system. Organizations running the full ConsentCollect App subscription gain access to verified comprehension tracking, automated signing sequence management, biometric signature seals, and FHIR R4 interoperability with Epic and Cerner platforms.

❓ Frequently Asked Questions

How do I import and configure this Deep Brain Stimulation document layout in the Free Builder?

Click the "Customize in Free Builder" button on this page. The form schema opens directly in the client-side ConsentCollect Free Builder canvas with all fields, sections, and signature blocks pre-loaded. You can then drag and drop additional fields, relabel any section header, swap placeholder text for your facility name and provider credentials, and rearrange the field order to match your clinic workflow, all without creating an account.

What document structure and field types does this Deep Brain Stimulation layout include?

This layout contains 13 structured sections covering patient identification fields, administrative intake data, and signature capture blocks. Practice managers and compliance officers can override any field label or placeholder value inside the builder to match their own intake schema.

Can I use this Deep Brain Stimulation template for my Neurology & Neurosurgery practice without a paid subscription?

Yes. The Free Advanced Form Builder is entirely public with no account required. You can open this deep brain stimulation layout, edit all fields, and export a print-ready PDF or copy the underlying JSON schema at no cost. A paid ConsentCollect App subscription unlocks additional workflow features such as encrypted transmission, timestamped audit logs, multi-party signing order, and direct FHIR R4 EHR integrations.

Does this page provide clinical, legal, or medical advice about deep brain stimulation procedures?

No. This page is an administrative document schema tool hosted by ConsentCollect, a B2B compliance software platform. The form layout is provided for operational and administrative configuration purposes only. ConsentCollect is not a law firm, healthcare provider, or clinical advisory service. Before deploying any consent document to patients, the finished form must be reviewed by your organization's qualified legal counsel and a licensed medical director to confirm compliance with applicable regulations in your jurisdiction.

How do I export, print, or integrate this Deep Brain Stimulation form schema into my EHR system?

After editing in the Free Builder, use the Export button to download a high-resolution PDF suitable for physical signature collection. Alternatively, copy the JSON schema payload for use in your own patient intake database or web application. Subscribers to the full ConsentCollect App can push finalized templates directly into Epic or Cerner workflows via a certified FHIR R4 integration layer without any manual re-entry.

Consent Form Moat